Correction: Siltuximab as a first-line therapy for idiopathic multicentric Castleman disease: a retrospective analysis based on the SiMuLa study of the Italian regional network
S. Pelliccia, A. Di Rocco, G. Palumbo, A. Zizzari, O. Annibali, E. Maiolo, A. Rago, G. Trapè, M. P. Bianchi, G. Pileggi, L. Filomeno, S. Hohaus, L. Rigacci, M. C. Cox, M. Martelli, G. La Verde, A. Di Napoli, A. Tafuri
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsViral-associated cancers and disorders · Multiple Myeloma Research and Treatments · Chronic Lymphocytic Leukemia Research